Your cart

There are no items in your shopping cart

TG100-115

Based on 23 reference(s) in Google Scholar 8 10 23

Axon 3974

CAS [677297-51-7]

MF C18H14N6O2
MW 346.34

  • Purity: 99%
  • Soluble in DMSO
Recently added

TG100-115

Description

A PI3K P110 ץ/δ isoform-selective inhibitor with IC50 values (nM) of 1300, 1200, 83 and 235 for p110α, p110β, P110 ץ, and P110δ isoforms, respectively.

KEYWORDS: TG100-115 | Supplier | PI3K P110 ץ/δ inhibitor | TG100-115 | TG100 115 | CT-TG115 | CAS [677297-51-7] | Phosphatidylinositol | PI3K | Inhibitor | Enzymes

Related Products

Axon ID Name Description From price
1282 BAG 956 PI3K and PDPK1 inhibitor €95.00
1362 PIK 90 PI3K inhibitor (p110-α specific) €85.00
1417 TGX 221 PI3K inhibitor (p110 β specific) €70.00
1912 GSK 2636771 dihydrochloride PI3K inhibitor (p110 β specific) €105.00
2170 CAL 101 PI3K inhibitor (p110 δ specific) €95.00
2168 IC 87114 Potent and highly selective inhibitor of the PI3K p110δ €85.00
2610 PDK1 inhibitor 2610 Dual PI3K/PDPK1 inhibitor; desmethyl analogue of Axon 1282 €125.00
2870 ML 221 Apelin receptor (APJ) antagonist €95.00
2926 AZD6482 PI3K inhibitor (p110 β specific) €120.00
2927 Taselisib PI3K inhibitor (p110 β sparing) €90.00
3045 PI 3065 PI3K inhibitor (p110 δ specific) €100.00
3098 ME-401 Potent, selective and orally available PI3K inhibitor (p110 δ specific) €100.00
3690 AZD8186 PI3Kβ/δ isoform-selective inhibitor Inquire
3792 PITCOIN3 Potent, highly selective and cell-permeable PI3KC2α inhibitor  Recently added €210.00

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Newsletter
Give Feedback
 
Send E-mail

Customer Support

About Axon Medchem

Download Product Catalog

Download the Axon Ligands™ catalogue 2021 Spring Edition

Follow Us

© 2016 Axon Medchem. All Rights Reserved.

Send us a message

×

Contact Us

* Required Fields

Please wait...